APPaRENT 3: Asthma Patients’ and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries

• Published in: Advances in Therapy
• Main Author: Aggarwal B.; Al-Moamary M.; Allehebi R.; Alzaabi A.; Al-Ahmad M.; Amin M.; Damayanti T.; Van Tho N.; Quyen P.T.L.; Sriprasart T.; Poachanukoon O.; Yu-Lin A.B.; Ismail A.I.; Limpin M.E.B.; Koenig S.; Levy G.; Phansalkar A.; Rafih F.; Silvey M.; Miriams L.; Milligan G.
• Format: Article
• Language: English
• Published: Adis 2024
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195908001&doi=10.1007%2fs12325-024-02900-2&partnerID=40&md5=7eb6b83e5fd946ed919e36c27585505b

Introduction: Asthma management is strongly dependent on physician and patient beliefs and perceptions about the disease and its long-term treatment. The APPaRENT 3 study was conducted to explore factors influencing treatment choice and to understand patients’ and physicians’ attitudes and perspectives on the use of controller inhalers in regular versus flexible dosing for asthma management. Methods: This cross-sectional survey of patients with asthma and treating physicians was conducted in seven countries: Indonesia, Malaysia, Philippines, Thailand, Vietnam (patient survey only), Saudi Arabia, and the United Arab Emirates. Assessment was carried out through an online/face-to-face questionnaire, where patients’ viewpoints were focused on their attitudes and beliefs about asthma and treatment adherence, whereas physicians’ viewpoints were gathered on their attitudes and beliefs about asthma management, knowledge of and adherence to asthma treatment guidelines, and asthma treatment regimens. Results: Overall, 1400 patients (mean age, 34 years) and 599 physicians (mean age, 43 years) were included in the survey. Physicians similarly prioritised symptom control (39%) and exacerbation reduction (40%) in moderate asthma, whereas patients prioritised symptom control (41%) over exacerbation reduction (22%). Although both groups (physicians, 86%; patients, 84%) perceived asthma as well-controlled, poor management was evident based on Asthma Control Test (ACT) scores (mean, 15.7; standard deviation, 4.14; 82% had an ACT score < 20) and high symptom burden (39% reported nighttime awakenings or early mornings ≥ 2 nights/week). Most patients (76%) with moderate asthma were prescribed regular dosing, with the most common treatment being inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) with as-needed inhaled short-acting β2-agonist (SABA; 20%). Among patients on maintenance and reliever therapy, 93% of patients received a separate inhaled reliever. Conclusions: Despite high symptom burden, patients overestimated their level of asthma control. Physicians prioritised controlling symptoms and reducing exacerbations as treatment goals for moderate asthma, often prescribing regular dosing with ICS/LABA with as-needed inhaled SABA. © The Author(s) 2024.